Wang Xin, an associate professor with School of Life Sciences has set a record in the history of pharmacology discipline in ECNU by receiving the 2016 Chinese Pharmacological Society (CNPHARS) Young Pharmacologists Award.
He collected the award for his distinguished achievements in drug metabolism research during the 14th national meeting of CNPHARS held in Beijing between October 22 and 25.
Wang Xin wins 2016 Young Pharmacologists Award.
Established by CNPHARS 20 years ago to commend outstanding young pharmacology researchers and boost development of the sector, the annual award goes to no less than nine winners each year.
Wang earned his doctorate in pharmacology at The Chinese University of Hong Kong in 2007 and left University of Texas Medical School where he worked as a postdoctoral fellow in 2011 to become a member of the Yangtze Scholar Innovation Team led by Prof. Liu Mingyao under School of Life Sciences.
Wang Xin is a member of the Yangtze Scholar Innovation Team led by Prof. Liu Mingyao.
His studies focus on drug metabolism control and innovative drug safety evaluation while his research in drug metabolism and metabolic enzyme is in a leading position worldwide. He has led projects of the National Natural Science Foundation of China, Shanghai Natural Science Foundation, and Laboratory Animal Innovation Fund under the Scientific Innovation Action Plan of Shanghai Science & Technology Commission. He has 40-strong essays published by internationally prestigious SCI magazines such as Nature Communications, Biochemical Pharmacology, and Pharmacological Research. Of the essays, 25 recorded him as the first author and corresponding author. He compiled a book on pharmacology independently, co-compiled four books, and has applied for four domestic patents. He took the world’s lead to build successfully the specific CYP metabolic enzyme knockout rat model with CRISPR/Cas9. The model is widely used in drug metabolism, chemical toxicity and carcinogenicity research. He filled a void by applying mice and 3-D organoids of human small intestines to in-vitro high throughput screening of p-glycoprotein inhibitor.
Now a contributing copy-editor of 26 world-famous SCI publications in multiple fields such as pharmacology, phytomedicine, metabolism and toxicology, Wang was honored the Outstanding Contribution Awards by Journal of Pharmaceutical and Biomedical Analysis in 2015 and Phytomedicine in 2016, respectively.